Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons

Addiction Biology

Volumn 20, Issue 1, 2015, Pages 104-119

  García Pérez, Daniel ^a,b   Lõpez Bellido, Roger ^c   Hidalgo, Juana M ^a,b   Rodríguez, Raquel E ^c   Laorden, Maria Luisa ^a,b   Núñez, Cristina ^a,b   Milanés, Maria Victoria ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b Murcia Biomedical Research Institute (IMIB)   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Ago2; miR 133b; morphine administration; morphine withdrawal; NAc; TH; VTA

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ARGONAUTE 2 PROTEIN; MICRORNA; MICRORNA 133B; MORPHINE; NALOXONE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; AGO2 PROTEIN, RAT; ARGONAUTE PROTEIN; MESSENGER RNA; MIRN133 MICRORNA, RAT; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE SYNTHESIS; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPIGENETICS; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MIDBRAIN DOPAMINERGIC NEURON; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; RAT; VENTRAL TEGMENTUM; WESTERN BLOTTING; WITHDRAWAL SYNDROME; ANIMAL; BRAIN; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCEPHALON; METABOLISM;

ANALGESICS, OPIOID; ANIMALS; ARGONAUTE PROTEINS; BRAIN; DOPAMINERGIC NEURONS; GENE EXPRESSION; MALE; MESENCEPHALON; MICRORNAS; MORPHINE; NUCLEUS ACCUMBENS; RATS; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 84919847994     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12083     Document Type: Article

References (47)

1. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
2. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Di Chiara G, (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
4. Di Chiara G, Bassareo V, (2007) Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7: 69-76.
5. Di Chiara G, Imperato A, (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accunbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244: 1067-1080.
6. Eipper-Mains JE, Kiraly DD, Palakodeti D, Mains RE, Eipper BA Graveley BR, (2011) MicroRNA-seq reveals cocaine-regulated expression of striatal microRNAs. RNA 17: 1529-1543.
7. Frenois F, Cador M, Caille S, Stinus L, Le Moine C, (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
8. García-Pérez D, Laorden ML, Milanes MV, Núñez C, (2012) Glucocorticoids regulation of FosB/ΔFosB expression induced by chronic opiate exposure in the brain stress system. PLoS One 7: e50264.
9. García-Pérez D, Sáez-Belmonte F, Laorden ML, Núñez C, Milanés MV, Milanés MV, (2013) Morphine administration modulates expression of argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function. Br J Pharmacol 168: 1889-1901.
10. Georges F, Le Moine C, Aston-Jones G, (2006) No effects of morphine on ventral tegmental dopamine neurons during withdrawal. J Neurosci 26: 5720-5726.
11. Heyer MP, Pani AK, Smeyne RJ, Kenny PJ, Feng G, (2012) Normal midbrain dopaminergic neuron development and function in MiR-133b mutant mice. J Neurosci 32: 10887-10894.
12. Hollander JA, Im HI, Amelio A, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ, (2010) Striatal microRNA controls cocaine intake through CREB signaling. Nature 466: 197-202.
13. Houshyar H, Manalo S, Dallman MF, (2004) Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci 24: 9414-9424.
14. Hutchison ER, Okun E, Mattson MP, (2009) The therapeutic potential of microRNAs in nervous system damage, degeneration and repair. Neuromol Med 11: 153-161.
15. Hutvagner G, Simard MJ, (2008) Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 9: 22-32.
16. Ikemoto S, (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56: 27-78.
17. Johnston M, Hutvagner G, (2011) Posttranslational modification of argonautes and their role in small RNA-mediated gene regulation. Silence 2: 1-4.
18. Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL, van den Oord EJCG, Riley BP, Kendler KS, Vladimirov VI, (2010) MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res 124: 183-191.
19. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A, (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317: 1220-1224.
20. Kim VN, Han J, Siomi MC, (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-138.
21. Kosik KS, (2006) The neuronal microRNA system. Nat Rev Neurosci 7: 911-920.
22. Laorden ML, Castells MT, Martínez MD, Martínez PJ, Milanés MV, (2000) Activation of C-Fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists. correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. Endocrinology 141: 1366-1376.
23. Lenartowski R, Goc A, (2011) Epigenetic, transcriptional and posttranscriptional regulation of the tyrosine hydroxylase gene. Int J Dev Neurosci 29: 873-883.
24. Leng A, Feldon J, Ferger B, (2004) Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav 77: 371-379.
25. Li MD, van der Vaart AD, (2011) MicroRNAs in addiction: adaptation's middlemen? Mol Psychiatry 16: 1159-1168.
26. Lippi G, Teinert JR, Marzylo ER, D'Oro S, Fiore R, Forsythe ID, Schratt G, Zoly M, Nicotera P, Young KW, (2011) Targeting of the Arpc3 actin nucleation factor by MiR-29a/b regulates dendritic spine morphology. J Cell Biol 194: 889-904.
27. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ, (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
28. Lodge DJ, Grace AA, (2012) Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia. Int J Neuropsychopharmacol 15: 69-76.
29. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH, Cha JH, Gether U, Wang H, Abeliovich A, (2006) Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci U S A 103: 2874-2879.
30. Maze I, Nestler EJ, (2011) The epigenetic landscape of addiction. Ann N Y Acad Sci 1216: 99-113.
31. Nakashima A, Hayashi N, Kaneko IS, Mori K, Sabban EL, Nagatsu T, Ota A, (2009) Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines. J Neural Transm 116: 1355-1362.
32. Nestler EJ, (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
33. Núñez C, Földes A, Pérez-Flores D, García-Borrõn JC, Laorden ML, Kovács KJ, Milanés MV, (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) MRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150: 3118-3127.
34. Paxinos G, Watson C, (2007) The Rat Brain in Stereotaxic Coordinates. Amsterdam, the Netherlands: Academic Press.
35. Perron MP, Provost P, (2009) Protein components of the microRNA pathway and human diseases. Methods Mol Biol 487: 369-385.
36. Reddy SD, Rayala SK, Ohshiro K, Pakala SB, Kobori N, Dash P, Yun S, Qin J, O'Malley BW, (2011) Multiple coregulatory control of tyrosine hydroxylase gene transcription. Proc Natl Acad Sci U S A 108: 4200-4205.
37. Renthal W, Nestler EJ, (2008) Epigenetic mechanisms in drug addiction. Trends Mol Med 14: 341-350.
38. Robison AJ, Nestler EJ, (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
39. Rodriguez RE, (2012) Morphine and microRNA activity: is there a relation with addiction? Front Genet 3: 223. doi: 10.3389/fgene.2012.00223.
40. Salvatore MF, Pruett BS, (2012) Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways. PLoS One 7: e29867.
41. Sanchez-Simon FM, Zhang XX, Loh HH, Law PY, Rodriguez RE, (2010) Morphine regulates dopaminergic neuron differentiation via MiR-133b. Mol Pharmacol 78: 935-942.
42. Schaefer A, Im HI, Veno MT, Fowler CD, Min A, Intrator A, Kjems J, Kenny PJ, O'Carroll D, Greengard P, (2010) Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med 207: 1843-1851.
43. Tapocik JD, Luu TV, Mayo CL, Wang B-D, Doyle E, Lee AD, Lee NH, Elmer GI, (2013) Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior. Addict Biol 18: 480-495.
44. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F, (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56: 3-8.
45. Volkow ND, Skolnick P, (2012) New medications for substance use disorders: challenges and opportunities. Neuropsychopharmacology 37: 290-292.
46. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, DiLeone RJ, Kumar A, Nestler EJ, (2006) An essential role for DFosB in the nucleus accumbens in morphine action. Nat Neurosci 9: 205-211.
47. Zangen A, Ikemoto S, Zadina JE, Wise RA, (2002) Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J Neurosci 22: 7225-7233.